The cell therapy landscape is rapidly evolving, driven by technological advancements, a surge in late-stage programs, and increasing cost pressures. As therapies become more complex and regulatory ...

For the very first time, Pieter Cullis, Professor at University of British Columbia will be speaking at the summit along with 50+ LNP industry leaders including: ...

Every time Kelsey publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

SRC navigates challenges among its 10 plants and roughly 1,800 employees companywide. That workforce includes around 1,550 ...

Developing new drugs is not for the faint-hearted. “It’s a pretty perilous journey,” says Paul Nioi, vice-president of discovery and translational research at Alnylam Pharmaceuticals. “It’s expensive ...

Background Hypertrophic cardiomyopathy (HCM) is associated with an increased risk of sudden cardiac death (SCD), and ...

Objectives To determine the prevalence of depressive and anxiety symptoms among young people 7 years and 9 years after ...

AI is not a replacement for the industrial workforce, but a tool whose value depends on human judgment, context, and ...

Objectives Spondylolysis is a common source of low back pain (LBP) among adolescent athletes. We aimed to investigate the ...

Objective To explore the prior knowledge and attitudes of community health workers (CHWs) in Ecuador regarding chronic ...